Psychedelic Policy Briefing: Week of June 29nd, 2026
Massachusetts advances two psychedelic therapy pilot bills, Louisiana's opioid-settlement-funded program takes effect August 1, and White House aide Heidi Overton lands on the FDA commissioner shortlist. The post Psychedelic Policy Briefing: Week of June 29nd, 2026 appeared first on Psychedelics Today.
External link. We are not responsible for the content.
Read more ↗More From Psychedelics Today
Weekly Psychedelic Policy Briefing – August 9, 2026
Jack Gorsline, investigative journalist, covers four federal developments this week. The Department of Veterans Affai...
Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?
MAPS co-executive director Ismail Lourido Ali on what the April 2026 executive order, the Texas and Colorado funding ...
The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science
An Emory study is recruiting 800 people who faced post-psychedelic challenges, to learn what recovery actually takes....
Latest News
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psych...
9 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Puerto Rico Makes Moves on Ibogaine, MDMA, and Psilocybin
The island's governor just signed an executive order effectively launching a pilot program to research psychedelic th...
Microdosing for Anxiety: What the Evidence Shows, and Where It Doesn’t
Microdosing for anxiety looks encouraging in open-label surveys and far less convincing under placebo control. What f...
The Toads Didn’t Consent to Being Milked, Sorry
Chasing "enlightenment" at the expense of desert toads is not the flex you think it is. [...] Read More... The post T...
Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing
For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Ey...